tiprankstipranks
Sorrento Therapeutics (SRNE)
NASDAQ:SRNE

Sorrento Therapeutics (SRNE) Technical Analysis

0 Followers

Technical Sentiment

Overall Consensus
Sell
4Bullish
5Neutral
13Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Sell
1Bullish
0Neutral
11Bearish
Sorrento Therapeutics’s (SRNE) Moving Averages Convergence Divergence (MACD) indicator is -0.20, suggesting Sorrento Therapeutics is a Buy.
Sorrento Therapeutics’s (SRNE) 20-Day exponential moving average is 0.53, while Sorrento Therapeutics’s (SRNE) share price is $0.307, making it a Sell.
Sorrento Therapeutics’s (SRNE) 50-Day exponential moving average is 0.81, while Sorrento Therapeutics’s (SRNE) share price is $0.307, making it a Sell.

Sorrento Therapeutics (SRNE) Pivot Points

Apr 26, 2024, 12:20 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.11
0.19
0.24
0.32
0.36
0.44
0.48
Fibonacci
0.19
0.24
0.27
0.32
0.36
0.39
0.44
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Sorrento Therapeutics (SRNE) Moving Averages

Apr 26, 2024, 12:20 AM
Period
Simple
Exponential
MA5
0.31Sell
0.31Sell
MA10
0.29Buy
0.38Sell
MA20
0.60Sell
0.53Sell
MA50
0.84Sell
0.81Sell
MA100
1.13Sell
1.09Sell
MA200
1.59Sell
1.47Sell
Sorrento Therapeutics’s (SRNE) 10-Day exponential moving average is 0.38, while Sorrento Therapeutics’s (SRNE) share price is $0.307, making it a Sell.
Sorrento Therapeutics’s (SRNE) 100-Day exponential moving average is 1.09, while Sorrento Therapeutics’s (SRNE) share price is $0.307, making it a Sell.
Sorrento Therapeutics’s (SRNE) stock price is $0.307 and Sorrento Therapeutics’s (SRNE) 50-day simple moving average is 0.84, creating a Sell signal.
Sorrento Therapeutics’s (SRNE) stock price is $0.307 and Sorrento Therapeutics’s (SRNE) 100-day simple moving average is 1.13, creating a Sell signal.
Sorrento Therapeutics’s (SRNE) stock price is $0.307 and Sorrento Therapeutics’s (SRNE) 200-day simple moving average is 1.59, creating a Sell signal.

Sorrento Therapeutics (SRNE) Technical Indicators

Apr 26, 2024, 12:20 AM
Name
Value
Implied Action
RSI (14)
34.06
Neutral
STOCH (9,6)
42.86
Neutral
STOCHRSI (14)
17.66
Buy
MACD (12,26)
-0.20
Buy
ADX (14)
27.53
Neutral
Williams %R
-84.87
Buy
CCI (14)
-59.46
Neutral
ATR (14)
0.13
-
Ultimate Oscillator
43.69
Neutral
ROC
-71.43
Sell
Sorrento Therapeutics’s (SRNE) Relative Strength Index (RSI) is 34.06, creating a Neutral signal.
Sorrento Therapeutics’s (SRNE) Trend Strength Indicator (ADX) is 27.53, creating a Neutral signal.
Sorrento Therapeutics’s (SRNE) Commodity Channel Index (CCI) is -59.46, creating a Neutral signal.
Sorrento Therapeutics’s (SRNE) Price Rate of Change (ROC) is -71.43, creating a Sell signal.

FAQ

Is SRNE a Buy, Hold, or Sell?
Based on SRNE’s technical indicators, SRNE is a Sell.
    What is SRNE’s RSI (14)?
    SRNE’s RSI (14) is 34.06, which suggests SRNE is a Neutral.
      What is SRNE’s MACD?
      SRNE’s MACD is -0.20, which suggests SRNE is a Buy.
        What is SRNE’s 5-day moving average?
        SRNE’s 5-day moving average is 0.31, which suggests SRNE is a Sell.
          What is SRNE’s 20-day moving average?
          SRNE 20-day moving average is 0.60, which suggests SRNE is a Sell.
            What is SRNE’s 50-day moving average?
            SRNE’s 50-day moving average is 0.84, which suggests SRNE is a Sell.
              What is SRNE’s 200-day moving average?
              SRNE’s 200-day moving average is 1.59, which suggests SRNE is a Sell.
                What is SRNE’s Williams % R (14)?
                SRNE’s Williams % R (14) is -84.87, which suggests SRNE is a Buy.
                  What is SRNE’s CCI (14)?
                  SRNE’s CCI (14) is -59.46, which suggests SRNE is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis